SCHEMBL6175170

SCHEMBL6175170

Cc1cnccc1C[C@@]1(C)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.44
KMT2A Q03164 1/20 0.39
AR P10275 4/20 0.38
TP53 P04637 1/20 0.36
NAMPT P43490 1/20 0.35
THRB P10828 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
ITGAL P20701 1/20 0.33
PTGS2 P35354 2/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL17558421 0.95 IGF1R (0.41) IGF1RKMT2AARTP53NAMPT
Trifluoroacetic Acid SCHEMBL17558372 0.95 IGF1R (0.41) IGF1RKMT2AARTP53NAMPT
SCHEMBL6175255 0.90 IGF1R (0.44) IGF1RKMT2AARTP53NAMPT
SCHEMBL6171403 0.89 IGF1R (0.43) IGF1RKMT2AARTP53NAMPT
SCHEMBL6173328 0.88 IGF1R (0.44) IGF1RKMT2AARTP53NAMPT
SCHEMBL6175523 0.87 IGF1R (0.41) IGF1RKMT2AARTP53NAMPT
SCHEMBL6174638 0.86 IGF1R (0.43) IGF1RKMT2AARTP53NAMPT
SCHEMBL6175293 0.86 IGF1R (0.45) IGF1RKMT2AARTP53NAMPT
SCHEMBL6176020 0.85 IGF1R (0.40) IGF1RKMT2AARTP53NAMPT
SCHEMBL6172334 0.85 IGF1R (0.40) IGF1RKMT2AARTP53NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP claimed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO claimed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed